Effect of a poly(<scp>ADP</scp>‐ribose) polymerase‐1 inhibitor against esophageal squamous cell carcinoma cell lines
Tomomitsu Nasuno(Kitasato University Hospital), Katsuya Tsuchihara(National Cancer Center Hospital East)
Cited by 14
Related Papers
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant
|International Journal of Clinical Oncology|2023|1